rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
11
|
pubmed:dateCreated |
2001-3-6
|
pubmed:abstractText |
Combination antiretroviral therapy with a combination of three or more drugs has become the standard of care for patients with human immunodeficiency virus (HIV) infection in the United States. We estimated the clinical benefits and cost effectiveness of three-drug antiretroviral regimens.
|
pubmed:grant |
|
pubmed:commentsCorrections |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
AIM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
0028-4793
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:day |
15
|
pubmed:volume |
344
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
824-31
|
pubmed:dateRevised |
2007-11-14
|
pubmed:meshHeading |
pubmed-meshheading:11248160-AIDS-Related Opportunistic Infections,
pubmed-meshheading:11248160-Anti-HIV Agents,
pubmed-meshheading:11248160-CD4 Lymphocyte Count,
pubmed-meshheading:11248160-Computer Simulation,
pubmed-meshheading:11248160-Cost-Benefit Analysis,
pubmed-meshheading:11248160-Direct Service Costs,
pubmed-meshheading:11248160-Disease Progression,
pubmed-meshheading:11248160-Drug Costs,
pubmed-meshheading:11248160-Drug Therapy, Combination,
pubmed-meshheading:11248160-HIV Infections,
pubmed-meshheading:11248160-Health Care Costs,
pubmed-meshheading:11248160-Humans,
pubmed-meshheading:11248160-Life Expectancy,
pubmed-meshheading:11248160-Models, Biological,
pubmed-meshheading:11248160-Quality-Adjusted Life Years,
pubmed-meshheading:11248160-RNA, Viral,
pubmed-meshheading:11248160-United States,
pubmed-meshheading:11248160-Value of Life
|
pubmed:year |
2001
|
pubmed:articleTitle |
The cost effectiveness of combination antiretroviral therapy for HIV disease.
|
pubmed:affiliation |
Division of General Internal Medicine and the Partners AIDS Research Center, Massachusetts General Hospital and Harvard Medical School, Boston 02114, USA. kfreedberg@partners.org
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, U.S. Gov't, P.H.S.
|